NDC 63629-3380
SEROQUEL
Quetiapine Fumarate
SEROQUEL is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Quetiapine Fumarate.
| Product ID | 63629-3380_1d454bae-1545-4c55-abd5-7ee56097229b |
| NDC | 63629-3380 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SEROQUEL |
| Generic Name | Quetiapine Fumarate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2006-02-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020639 |
| Labeler Name | Bryant Ranch Prepack |
| Substance Name | QUETIAPINE FUMARATE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 63629-3380-1
30 TABLET, FILM COATED in 1 BOTTLE (63629-3380-1)
| Marketing Start Date | 2006-02-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 63629-3380-3 [63629338003]
SEROQUEL TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA020639 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-02-13 |
| Inactivation Date | 2019-11-27 |
NDC 63629-3380-4 [63629338004]
SEROQUEL TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA020639 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-02-13 |
| Inactivation Date | 2019-11-27 |
NDC 63629-3380-2 [63629338002]
SEROQUEL TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA020639 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-02-13 |
| Inactivation Date | 2019-11-27 |
NDC 63629-3380-1 [63629338001]
SEROQUEL TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA020639 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-02-13 |
| Inactivation Date | 2019-11-27 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| QUETIAPINE FUMARATE | 50 mg/1 |
OpenFDA Data
| SPL SET ID: | 600bc03b-7ccd-4a26-b0d4-94b7968758b1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Atypical Antipsychotic [EPC]
NDC Crossover Matching brand name "SEROQUEL" or generic name "Quetiapine Fumarate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 21695-119 | SEROQUEL | SEROQUEL |
| 21695-117 | SEROQUEL | SEROQUEL |
| 21695-118 | SEROQUEL | SEROQUEL |
| 21695-120 | SEROQUEL | SEROQUEL |
| 55289-447 | SEROQUEL | SEROQUEL |
| 55289-187 | SEROQUEL | SEROQUEL |
| 55289-872 | SEROQUEL | SEROQUEL |
| 0310-0274 | SEROQUEL | SEROQUEL |
| 0310-0278 | SEROQUEL | SEROQUEL |
| 0310-0271 | SEROQUEL | SEROQUEL |
| 0310-0272 | SEROQUEL | SEROQUEL |
| 0310-0279 | SEROQUEL | SEROQUEL |
| 0310-0275 | SEROQUEL | SEROQUEL |
| 63629-3378 | SEROQUEL | SEROQUEL |
| 63629-3291 | SEROQUEL | SEROQUEL |
| 63629-3380 | SEROQUEL | SEROQUEL |
| 63629-3319 | SEROQUEL | SEROQUEL |
| 67046-666 | SEROQUEL | SEROQUEL |
| 67046-662 | SEROQUEL | SEROQUEL |
| 67046-664 | SEROQUEL | SEROQUEL |
| 67046-661 | SEROQUEL | SEROQUEL |
| 67046-660 | SEROQUEL | SEROQUEL |
| 67046-663 | SEROQUEL | SEROQUEL |
| 70518-2166 | SEROQUEL | SEROQUEL |
| 70518-2424 | SEROQUEL | SEROQUEL |
| 0054-0220 | Quetiapine Fumarate | Quetiapine Fumarate |
| 0054-0221 | Quetiapine Fumarate | Quetiapine Fumarate |
| 0054-0222 | Quetiapine Fumarate | Quetiapine Fumarate |
| 0054-0223 | Quetiapine Fumarate | Quetiapine Fumarate |
| 0054-0229 | Quetiapine Fumarate | Quetiapine Fumarate |
| 0054-0230 | Quetiapine Fumarate | Quetiapine Fumarate |
Trademark Results [SEROQUEL]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SEROQUEL 73724400 1517746 Live/Registered |
IMPERIAL CHEMICAL INDUSTRIES PLC 1988-04-25 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.